1423|1042|Public
5|$|Metformin {{decreases}} {{high blood}} sugar, primarily by suppressing liver glucose production (hepatic gluconeogenesis). The average patient with {{type 2 diabetes}} has three times the normal rate of gluconeogenesis; metformin treatment reduces this by over one-third. The molecular mechanism of metformin is incompletely understood. Multiple potential mechanisms of action have been proposed, including; inhibition of the mitochondrial respiratory chain (complex I), activation of AMP-activated protein kinase (AMPK), inhibition of glucagon-induced elevation of <b>cyclic</b> <b>adenosine</b> <b>monophosphate</b> (cAMP) with reduced activation of protein kinase A (PKA), inhibition of mitochondrial glycerophosphate dehydrogenase, and an effect on gut microbiota.|$|E
25|$|Gsα {{subsequently}} activates adenylyl cyclase, {{increasing the}} intracellular {{concentration of the}} second messenger <b>cyclic</b> <b>adenosine</b> <b>monophosphate</b> (cAMP).|$|E
25|$|There are {{two main}} {{receptor}} types associated with the endocannabinoid signaling system; cannabinoid receptor 1 (CB1) and 2 (CB2). Both receptors are 7-transmembrane G-protein coupled receptors (GPCRs) which inhibit the accumulation of <b>cyclic</b> <b>adenosine</b> <b>monophosphate</b> within cells. CB1 receptors are present in highest concentration in the brain but {{can also be found}} in the periphery. CB2 receptors are mostly located in the immune and haematopoietic systems.|$|E
50|$|One {{example of}} {{crosstalk}} between proteins in a signalling pathway {{can be seen}} with <b>cyclic</b> <b>adenosine</b> <b>monophosphate's</b> (cAMP) role in regulating cell proliferation by interacting with the mitogen-activated protein (MAP) kinase pathway. cAMP is a compound synthesized in cells by adenylate cyclase {{in response to a}} variety of extracellular signals. cAMP primarily acts as an intracellular second messenger whose major intracellular receptor is the cAMP-dependent protein kinase (PKA) that acts through the phosphorylation of target proteins. The signal transduction pathway begins with ligand-receptor interactions extracellularly. This signal is then transduced through the membrane, stimulating adenylyl cyclase on the inner membrane surface to catalyze the conversion of ATP to cAMP.|$|R
5000|$|W. Kadima, P. Raharivelomanana and B. Bechtel: The binding of <b>cyclic</b> <b>adenosine</b> 3′, 5′ <b>monophosphate</b> to the insulin hexamer. Jan 1997, Protein and Peptide Letters.|$|R
40|$|The β 2 -adrenergic {{receptor}} (β 2 AR) is a prototypical Gs-coupled receptor {{belonging to}} the superfamily of seven transmembrane spanning heptahelical receptors (7 TMRs or G protein-coupled receptors [GPCRs]) —therapeutically the most diverse and accessible class of cell surface receptors. The classic pathway of β 2 AR signaling (Fig. 1) is triggered by activation of the heterotrimeric G protein Gs by agonists (catecholamines—noradrenaline and adrenaline). This in turn activates adenylyl cyclase leading to the generation of second messenger signaling molecules (<b>cyclic</b> <b>adenosine</b> <b>monophosphates,</b> cAMP) which subsequently activate protein kinase A (PKA) {{as well as some}} ion channels, such as the class C type of L-type calcium channels, Cav 1. 2. 31 Here in we review how trafficking and signaling of the β 2 AR is regulated by the post-translational modification, ubiquitination. ...|$|R
25|$|Numerous melanocortin, MCH and {{melatonin}} receptors {{have been}} identified in fish and frogs, including a homologue of MC1R, a melanocortin receptor known to regulate skin and hair colour in humans. It has been demonstrated that MC1R is required in zebrafish for dispersion of melanin. Inside the cell, <b>cyclic</b> <b>adenosine</b> <b>monophosphate</b> (cAMP) {{has been shown to be}} an important second messenger of pigment translocation. Through a mechanism not yet fully understood, cAMP influences other proteins such as protein kinase A to drive molecular motors carrying pigment containing vesicles along both microtubules and microfilaments.|$|E
25|$|Direct {{sympathetic}} innervation of the {{salivary glands}} takes place via preganglionic nerves in the thoracic segments T1-T3 which synapse in the superior cervical ganglion with postganglionic neurons that release norepinephrine, {{which is then}} received by β-adrenergic receptors on the acinar and ductal cells of the salivary glands, leading {{to an increase in}} <b>cyclic</b> <b>adenosine</b> <b>monophosphate</b> (cAMP) levels and the corresponding increase of saliva secretion. Note that in this regard both parasympathetic and sympathetic stimuli result in an increase in salivary gland secretions. The sympathetic nervous system also affects salivary gland secretions indirectly by innervating the blood vessels that supply the glands.|$|E
25|$|Earl Wilbur Sutherland won the 1971 Nobel Prize in Physiology or Medicine ″for his discoveries {{concerning}} {{the mechanisms of}} the action of hormones″, in particular the discovery of <b>cyclic</b> <b>adenosine</b> <b>monophosphate</b> as second messenger in the action of catecholamines at β-adrenoceptors and of glucagon at glucagon receptors, which led on {{to the discovery of}} heterotrimeric G proteins. In 1988 James Black was one of three winners of the Nobel Prize in Physiology or Medicine ″for their discoveries of important principles for drug treatment″, Black’s ″important principles″ being the blockade of β-adrenoceptors and of histamine H2 receptors. In 2012, Robert Lefkowitz and Brian Kobilka shared the Nobel Prize in Chemistry ″for studies of G-protein-coupled receptors″.|$|E
50|$|Soluble adenylyl cyclase (sAC) is a {{regulatory}} cytosolic enzyme present {{in almost every}} cell. sAC {{is a source of}} <b>cyclic</b> <b>adenosine</b> 3’,5’ <b>monophosphate</b> (cAMP) - a second messenger that mediates cell growth and differentiation in organisms from bacteria to higher eukaryotes. sAC differentiates from the transmembrane adenylyl cyclase (tmACs) - an important source of cAMP; in that sAC is regulated by bicarbonate anions and it is dispersed throughout the cell cytoplasm. sAC has been found to have various functions in physiological systems {{different from that of the}} tmACs.|$|R
40|$|Plasma {{concentrations}} of <b>cyclic</b> nucleotides (<b>adenosine</b> <b>monophosphate</b> (AMP) and guanosine monophosphate (GMP) were measured by an ultrasensitive radioimmunoassay in 138 patients with heart failure due to various causes. Measurements {{were related to}} the New York Heart Association classification of symptoms, plasma noradrenaline concentrations, and mean pulmonary artery pressures. Serial {{concentrations of}} cyclic AMP and GMP were also measured daily in four patients treated for acute left ventricular failure. Plasma concentrations of cycle AMP {{were related to the}} severity of the heart failure, plasma noradrenaline concentrations, and pulmonary artery pressures. Cyclic AMP concentrations fell rapidly after treatment of acute left ventricular failure. Plasma concentrations of cyclic GMP also depended on the severity of heart failure and the pulmonary artery pressure, and decreased sharply with treatment although remaining at a high value. The cyclic GMP concentrations were significantly higher in patients with mitral stenosis than in those with other types of heart failure...|$|R
30|$|Several other HU-mediated {{mechanisms}} of disease amelioration {{have been reported}} including production of nitric oxide, regulation of soluble guanylyl cyclase, <b>cyclic</b> <b>adenosine</b> and guanosine <b>monophosphate</b> [36, 37] as well as erythropoietic stress response [38]. Furthermore, various signalling pathways have been implicated in HU-mediated fetal hemoglobin (HbF) induction such as the Giα/JNK/Jun [39]; p 38 /MAPK/CREB 1 [40]; cAMP-mediated response [41, 42]; erythropoietin (EPO)-induced activation of the ERK- 1 /ERK- 2 MAPK [43]; histone deacetylase (HDAC) and DNA methyl-transferase (DNMT) inhibitor-mediated epigenetic modification of γ-globin expression. Despite this, a complete understanding of HU-mediated HbF production remains incomplete.|$|R
25|$|The binding of {{melatonin}} to melatonin receptors activates a few signaling pathways. MT1 receptor activation inhibits the adenylyl cyclase and its inhibition {{causes a}} rippling effect of non activation; starting with decreasing formation of <b>cyclic</b> <b>adenosine</b> <b>monophosphate</b> (cAMP), and then progressing to less protein kinase A (PKA) activity, {{which in turn}} hinders the phosphorylation of cAMP responsive element-binding protein (CREB binding protein) into P-CREB. MT1 receptors also activate phospholipase C (PLC), affect ion channels and regulate ion flux inside the cell. The binding of melatonin to MT2 receptors inhibits adenylyl cyclase which decreases the formation of cAMP. As well it hinders guanylyl cyclase and therefore the forming of cyclic guanosine monophosphate (cGMP). Binding to MT2 receptors probably affects PLC which increases protein kinase C (PKC) activity. Activation of the receptor can lead to ion flux inside the cell.|$|E
25|$|Phosphodiesterase 4 is {{a member}} of the {{phosphodiesterase}} family of proteins that cleave phosphodiester bonds. This is an important step in degrading <b>cyclic</b> <b>adenosine</b> <b>monophosphate</b> (cAMP), a major intracellular signaling molecule; conversely, blocking PDE4 will increase cAMP. Increased intracellular cAMP levels in neurons has been previously shown to induce axonal growth. In 2004, Nikulina et al. showed that administration of rolipram, a PDE4 inhibitor, can increase cAMP levels in neurons after spinal cord injury. This is partially possible because rolipram is sufficiently small to pass through the blood–brain barrier and immediately begin to catalyze reactions in neurons. 10 day administration of rolipram in spinal cord injured rodents resulted in considerable axonal growth associated with a reduction in glial scarring at 2 weeks post-injury. The mechanism for this reduction in glial scarring is currently unknown, but possible mechanisms include axonal extensions that physically prevent reactive astrocytes from proliferating, as well as chemical signaling events to reduce reactive astrogliosis.|$|E
2500|$|A cyclic {{nucleotide}} (cNMP) is a single-phosphate nucleotide with a cyclic bond arrangement {{between the}} sugar and phosphate groups. [...] Like other nucleotides, cyclic nucleotides are composed of three functional groups: a sugar, a nitrogenous base, and a single phosphate group. [...] As {{can be seen in}} the <b>cyclic</b> <b>adenosine</b> <b>monophosphate</b> (cAMP) and cyclic guanosine monophosphate (cGMP) images, the 'cyclic' portion consists of two bonds between the phosphate group and the 3' and 5' hydroxyl groups of the sugar, very often a ribose.|$|E
40|$|AbstractLow-density lipoproteins {{activate}} isolated human platelets. The {{mechanism of}} this activation is unknown, but may involve increased phosphoinositide turnover. We {{have examined the}} effect of low-density lipoproteins on intracellular calcium concentrations in platelets loaded with the photoprotein aequorin. The lipoproteins induced concentration-dependent increases in intracellular calcium, associated with shape change and aggregation. These responses could be partially inhibited by the removal of extracellular calcium and by pre-incubation with acetylsalicylic acid. They were also antagonised by agents which increase cellular concentrations of <b>cyclic</b> <b>adenosine</b> and guanosine <b>monophosphates.</b> It {{is not clear whether}} the platelet-lipoprotein interaction involves a ‘classical’ lipoprotein receptor...|$|R
40|$|Background: Recent {{studies have}} {{revealed}} that the properties Traditional Chinese Medicine is mostly associated with are substance and energy metabolism. Our study aimed to compare the effect of red ginseng (RG) (warm property) and ginseng leaves (GL; cold property) on the substance and energy metabolism of rats with hypothyroidism. Materials and methods: Rats were administered propylthiouracil intraperitoneally for 20 d to cause hypothyroidism. The reference group was orally administered Aconiti Lateralis Radix Praeparaia [FZ (Fuzi in Chinese) ], while both the RG and GL groups were orally administrated crude drugs. The rectal, tail, toe, and axilla temperature of the rats were assayed every 3 d. Oxygen consumption, carbon dioxide production, heat production, and energy expenditure were measured via TSE phenoMaster/LabMaster animal monitoring system. Adenosine monophosphate-activated protein kinase, Na+-K+-ATPase, fumarase, pyruvic acid and <b>cyclic</b> <b>adenosine</b> monophosphate/cyclic guanosine <b>monophosphate</b> were determined. Results: The lower levels of triiodothyronine, tetraiodothyronine, and thyrotropin-releasing hormone and the higher level of thyroid stimulating hormone revealed the successful establishment of a hypothyroidism model. Oxygen consumption, carbon dioxide production, heat production, and energy expenditure in the FZ and RG groups were obviously increased. The activity of Na+-K+-ATPase and fumarase in the FZ and RG groups was significantly increased. The <b>cyclic</b> <b>adenosine</b> monophosphate/cyclic guanosine <b>monophosphate</b> level in the FZ and RG groups was increased, while the GL group showed the opposite. Conclusion: Our research provides {{a new way to}} explore the efficiency of Chinese medicine {{on the basis of the}} relationship between drug property and effects on substance and energy metabolism...|$|R
40|$|AbstractVasodilator-stimulated phosphoprotein (VASP), an actin binding protein {{localized}} {{to areas}} of focal contacts, is a substrate for the <b>cyclic</b> <b>adenosine</b> monophosphate/cyclic guanosine <b>monophosphate</b> (cAMP/cGMP) -dependent protein kinases (PKA, PKG). In this study, {{we show that}} serum stimulation of vascular smooth muscle cells (SMCs) induces VASP phosphorylation on Ser 157, in a mechanism not dependent on PKA or PKG. We tested the possibility that protein kinase C (PKC), a regulator of cytoskeletal function, is involved. PKC inhibition or down-regulation prevented serum-induced phosphorylation of VASP at Ser 157 in rat vascular SMCs. Additionally, recombinant PKCα directly phosphorylated Ser 157 on VASP. In summary, our data {{support the hypothesis that}} PKC phosphorylates VASP and mediates serum-induced VASP regulation...|$|R
2500|$|Niacin's {{therapeutic}} {{effects are}} partly mediated through the activation of G protein-coupled receptors, including niacin receptor 1 (NIACR1) and niacin receptor 2 (NIACR2) which are highly expressed in adipose tissue, spleen, immune cells and keratinocytes {{but not in}} other expected organs such as liver, kidney, heart or intestine. NIACR1 and NIACR2 inhibit <b>cyclic</b> <b>adenosine</b> <b>monophosphate</b> (cAMP) production and thus fat breakdown in adipose tissue and free fatty acids available for liver to produce triglycerides and [...] very-low-density lipoproteins (VLDL) and consequently low-density lipoprotein (LDL) or [...] "bad" [...] cholesterol. Decrease in free fatty acids also suppress hepatic expression of apolipoprotein C3 (APOC3) and PPARg coactivator-1b (PGC-1b) thus increase VLDL turn over and reduce its production. It also inhibits diacylglycerol acyltransferase-2 (important hepatic TG synthesis).|$|E
50|$|The {{name has}} no {{relationship}} to <b>cyclic</b> <b>adenosine</b> <b>monophosphate</b> (cAMP).|$|E
50|$|One {{hormone that}} is used by many fungi is <b>Cyclic</b> <b>adenosine</b> <b>monophosphate</b> (cAMP).|$|E
40|$|Cyclic dinucleotides such as cyclic dimeric {{guanosine}} <b>monophosphate</b> (c-di-GMP,) <b>cyclic</b> dimeric <b>adenosine</b> <b>monophosphate</b> (c-di-AMP) and <b>cyclic</b> guanosine-adenosine monophosphate (cGAMP) {{are found}} in both prokaryotes and eukaryotes and are important in cell signaling processes. The work discussed herein aims at understanding the aggregative properties of these cyclic dinucleotides for interest in the biological implications of aggregation and {{for the purpose of}} various applications of these higher order structures. The applications include simple detection methods for these molecules as well as a unique G-quadruplex peroxidase {{that can be used for}} catalysis. To that end, a new fluorescent cyclic dinucleotide which incorporated the fluorescent purine analog, 2 -aminopurine, was synthesized. This analog is capable of forming intercalated dimers with natural cyclic dinucleotides containing guanine which allows for a simple turn-off fluorescent method for these second messengers. Additionally, ligands containing four guanine bases were utilized to bind c-di-GMP and leading to a fluorescent turn-on fluorescent detection method. The c-di-GMP octamer was also studied for its ability to enhance the peroxidation ability of the iron-containing cofactor hemin. Its proficient ability to enhance catalysis suggests that DNA loops found in other G-quadruplex forming molecules are not necessary for catalytic enhancement of hemin...|$|R
40|$|The {{activity}} of phosphodiesterases (PDEs) {{is associated with}} a wide variety of diseases and an intense effort toward the development of specific PDEs inhibitors has been generated for the last years. They are the enzymes responsible for the hydrolysis of intracellular <b>cyclic</b> <b>adenosine</b> and guanosine <b>monophosphate,</b> and their complexity, as well as their different functional role, makes these enzymes a very attractive therapeutic target. This review is focused on the role of PDEs played on immunomodulatory processes and the advance on the development of specific inhibitors, covering PDEs mainly related to the regulation of autoimmune processes, PDE 4 and PDE 7. The review also highlights the novel structural classes of PDE 4 and PDE 7 inhibitors, and the therapeutic potential that combined PDE 4 /PDE 7 inhibitors offer as immunomodulatory agents. © 2004 Wiley Periodicals, Inc. Peer Reviewe...|$|R
40|$|Infection {{of human}} {{fibroblasts}} and HEp- 2 cells with {{herpes simplex virus}} type 1 (HSV- 1) produced {{a decrease in the}} intracellular levels of <b>cyclic</b> <b>adenosine</b> 5 '- <b>monophosphate</b> (cAMP) and a concomitant increase in the cyclic guanosine 5 '- monophosphate (cGMP) levels. In both cell cultures, changes in cyclic nucleotide levels were first observed at 6 h after viral inoculation and were maximal at 12 h. In human fibroblasts, the addition of theophylline, dibutyryl cAMP, or papaverine (cAMP-enhancing compounds) decreased significantly the yield of HSV- 1, whereas the addition of insulin or dibutyryl cGMP (cGMP-enhancing compounds) increased the viral yield. In HEp- 2 cells, only theophylline decreased the yield of HSV- 1, and the cGMP-enhancing compounds had no apparent effect. Cyclic nucleotide enhancing compounds exhibited their effect only if added to either cell culture within the first 3 h after inoculation with HSV- 1...|$|R
50|$|For his {{insightful}} {{contributions to}} {{the recognition of the}} pervasive biological importance of <b>cyclic</b> <b>adenosine</b> <b>monophosphate.</b>|$|E
50|$|Gsα {{subsequently}} activates adenylyl cyclase, {{increasing the}} intracellular {{concentration of the}} second messenger <b>cyclic</b> <b>adenosine</b> <b>monophosphate</b> (cAMP).|$|E
50|$|GPR126 {{was shown}} to bind {{collagen}} IV and laminin-211 promoting <b>cyclic</b> <b>adenosine</b> <b>monophosphate</b> (cAMP) to mediate myelination.|$|E
40|$|This paper {{reports the}} growth and {{differentiation}} of the mouse embryonal carcinoma cell line F 9 in completely defined culture media. The defined growth medium, referred to as EM- 3, contains plasma fibronectin, insulin, and transferrin in place of serum. F 9 cells cultured in EM- 3 for over 15 generations retain their ability to form tumors and to differentiate. Fibronectin {{is essential for the}} attachment of F 9 cells in defined media and its effect can be blocked with affinity-purified anti-fibronectin. When retinoic acid was added to EM- 3, the F 9 cells differentiated. The majority of the the newly formed cells differed from patient F 9 cell two major respects: (i) they were morphologically different; and (ii) they secreted plasminogen activator, and the secretion was stimulated by dibutyrlyl <b>adenosine</b> <b>cyclic</b> <b>monophosphate...</b>|$|R
40|$|Rat megakaryocytes {{in mixed}} bone marrow cell {{suspension}} underwent mor phologic change {{when exposed to}} adenosine diphosphate (ADP) and epi nephrine. Viewed by phase microscopy, marginal membranes developed ragged or vacuolated appearance within one minute after exposure to ADP or epinephrine. Recovery from the change induced by ADP occurred within five minutes. These effects were inhibited by prior incubation of the cell sus pension with dibutyryl <b>adenosine</b> <b>cyclic</b> <b>monophosphate</b> (DBcAMP) and were not produced by <b>adenosine</b> <b>monophosphate</b> (AMP) or <b>adenosine</b> triphosphate (ATP). The results suggest that megakaryocyte membranes react with agents known to effect platelets and {{lend support to the}} indications that demarcating membranes of megakaryocytes derive from the megakaryocyte plasma mem brane. No observations were made which relate these observed changes to the release of platelets from megakaryocytes. Introd u ction On the basis of biochemical 1 and mor phologic 2 evidence, {{it has been suggested that}} the demarcating membranes of mega karyocytes, and therefore platelet mem branes, derive from the plasma membranes of megakaryocytes, and not from smooth endoplasmic reticulum 3 or Golgi vesicles. If this were so, it would be reasonable to expect that the plasma membrane of mega karyocytes would be functionally similar to the platelet membrane and would be re active to platelet-active substances. This report, therefore, describes the effect of adenosine diphosphate and epinephrin...|$|R
50|$|<b>Adenosine</b> <b>monophosphate</b> deaminase is {{an enzyme}} that {{converts}} <b>adenosine</b> <b>monophosphate</b> (AMP) to inosine monophosphate (IMP), freeing an ammonia molecule in the process.|$|R
50|$|Cyclic {{guanosine}} triphosphate (cGTP) helps <b>cyclic</b> <b>adenosine</b> <b>monophosphate</b> (cAMP) activate cyclic nucleotide-gated ion channels in the olfactory system.|$|E
50|$|The <b>cyclic</b> <b>adenosine</b> <b>monophosphate</b> (cAMP) assay in overexpressing HEK293 cells has {{demonstrated}} coupling of GPR114 to Gαs protein.|$|E
5000|$|... #Caption: <b>Cyclic</b> <b>adenosine</b> <b>mono{{phosphate}}.</b> The cyclic portion {{refers to}} the two single bonds between the phosphate group and the ribose ...|$|E
50|$|For example, it {{converts}} <b>adenosine</b> <b>monophosphate</b> to <b>adenosine,</b> and guanosine <b>monophosphate</b> to guanosine.|$|R
40|$|Results are {{presented}} for an experimental study intended to assess phosphorylation under neither aqueous nor dry thermal conditions. Instead, phosphorylations were attempted in possible nonaqueous prebiotic solvents. Formamide {{appeared to be}} the most obvious candidate for phosphorylation studies. Three main classes of phosphorylated products were formed in formamide solution: <b>adenosine</b> <b>monophosphates,</b> <b>cyclic</b> <b>adenosine</b> phosphate, and adenosine diphosphates. Experiments were designed to investigate the extent of phosphorylation of nucleosides in formamide, the relative amounts of nucleoside monophosphate, diphosphates and cyclic phosphate formed and the relative effectiveness of different sources of phosphate as phosphorylating agents in formamide. Reaction variables were temperature, nature of the phosphate or condensed phosphate, nucleoside, concentration of reactants and possible effects of additives. Product identification was based on qualitative and quantitative thin layer chromatography...|$|R
5000|$|... #Article: <b>Adenosine</b> <b>monophosphate</b> deaminase {{deficiency}} type 1 ...|$|R
